Creatine: The Most-Studied Supplement and What It Actually Does

That word, proposed, matters. Much of the brain-focused research is early: small samples, short durations, mechanistic hypotheses rather than large outcome trials. A single high dose during acute sleep deprivation producing measurable changes in brain energy metabolism and processing speed in one study is interesting and worth following. It is not the same as proof that daily creatine improves cognition in a well-rested, healthy adult, and it is a long way from proof that it slows any diagnosed neurodegenerative disease. Claims circulating online about dramatic slowing of Alzheimer's progression are getting ahead of what controlled trials have actually established; that specific claim needs a large, properly controlled clinical trial with cognitive and biomarker endpoints before it should be treated as fact, not the preliminary studies currently available.

Depression research is genuinely promising but early

A 2025 trial testing five grams of creatine daily as an add-on to cognitive behavioral therapy for depression found the combination significantly improved depressive symptoms compared with therapy alone. That is a real, structured randomized signal, but it is one trial in one specific context (as an adjunct to therapy, not a standalone treatment) and needs replication before it changes clinical practice.

Dosage and safety, what is actually established

Mayo Clinic and Cleveland Clinic both describe a typical maintenance dose of roughly 3 to 5 grams per day for healthy adults as the standard, well-tolerated regimen; some research suggests postmenopausal women may benefit from somewhat higher intake, an emerging area of interest given differences in baseline muscle mass and creatine synthesis by sex and life stage. Creatine is not generally harmful to kidneys in people with healthy kidney function, but the clinics are consistent that people with existing kidney disease, or significant risk factors for it, should avoid high-dose supplementation and talk to a clinician first, since research in that population is limited. Oral creatine at standard doses appears likely safe for continuous use up to five years based on available safety data, though evidence in pregnancy, breastfeeding and liver disease remains insufficient to draw firm conclusions.

Who is a reasonable candidate, and who should pause

Someone doing regular resistance training who wants a well-documented, cheap way to support strength and lean mass gains fits squarely inside where the muscle evidence is strongest. Someone with existing kidney disease, someone pregnant or breastfeeding, or someone hoping creatine alone will meaningfully slow a diagnosed neurodegenerative condition is stepping past what the current evidence actually supports, and each of those situations calls for a conversation with a clinician rather than a default yes.

Where the evidence is genuinely thin

The Alzheimer's and broad neurodegeneration claims, the idea that creatine measurably slows cognitive decline in diagnosed dementia, rest on limited human trial data so far. What would settle it: large, multi-year, placebo-controlled trials in diagnosed patient populations with validated cognitive endpoints and brain imaging or biomarker confirmation, the same rigor that established creatine's muscle benefits decades ago.

This article is reporting on supplement research, not medical advice. Anyone with kidney disease, liver disease, or who is pregnant or breastfeeding should talk with a clinician before starting creatine, and the same goes for anyone combining it with prescription medication.

Creatine remains a rare case of a supplement whose core claim, better strength and muscle performance, was proven the hard way, through decades of trials before it became a trend. The brain research deserves the same patience rather than a shortcut straight to miracle framing.